RPS4XP19

Across TCGA pan-cancer cohorts, RPS4XP19 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RPS4XP19’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPS4XP19 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS4XP19 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

COAD, BRCA, and KICH are the cancer types where RPS4XP19 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS4XP19 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+0.271	.005	6	view →
BRCA	All	All	+0.062	.007	4	view →
KICH	Female	All	−0.050	.009	2	view →
HNSC	Male	All	+0.055	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RPS4XP19–COAD

Open the COAD breakdown →